Table 2 Comparison of variables according to high (> 4) and low (≤ 4) mNUTRIC score
Variables | Total patients (n = 445) | Patients with low mNUTRIC score (n = 383) | Patients with high mNUTRIC score (n = 62) | P-value | |
|---|---|---|---|---|---|
Age | Mean ± SD | 61.35 ± 10.88 | 61.41 ± 11.08 | 61.02 ± 9.62 | 0.791 |
Gender | Male (%) | 230 (51.7) | 192 (50.1) | 38 (61.3) | 0.103 |
| Â | Female (%) | 215 (48.3) | 191 (49.9) | 24 (38.7) | Â |
Comorbidities | Yes (%) | 257 (57.8) | 218 (56.9) | 39 (62.9) | 0.376 |
| Â | No (%) | 188 (42.2) | 165 (43.1) | 23 (37.1) | Â |
APACHE II | Mean ± SD | 21.07 ± 4.27 | 19.98 ± 2.59 | 27.75 ± 6.17 | < 0.001* |
|  | Median (IQR) | 20 (18–23) | 20 (18–22) | 29 (23–33) |  |
SOFA | Mean ± SD | 10.45 ± 2.06 | 9.95 ± 1.305 | 13.58 ± 2.97 | < 0.001* |
|  | Median (IQR) | 10 (9–11) | 10 (9–11) | 14.5 (11–16) |  |
GVR more than | Yes (%) | 62 (13.9) | 28 (7.3) | 34 (54.8) | < 0.001* |
200Â cc | No (%) | 383 (86.1) | 355 (92.7) | 28 (45.2) | Â |
Dysglycemia | Yes (%) | 57 (12.8) | 36 (9.4) | 21 (33.9) | < 0.001* |
| Â | No (%) | 388 (87.2) | 347 (90.6) | 41 (66.1) | Â |
Type of nutrition | Enteral (%) | 385 (86.5) | 325 (91.9) | 33 (53.2) | < 0.001* |
| Â | Parenteral (%) | 52 (11.7) | 31 (8.1) | 21 (33.9) | Â |
| Â | Enteral and Parenteral | 8 (1.8) | 0 | 8 (12.9) | Â |
Received energy | Mean ± SD | 1636.5 ± 136.97 | 1643.94 ± 128.05 | 1591.13 ± 177.30 | 0.005* |
(Kcal) | Median (IQR) | 1650 (1600–1700) | 1650 (1600–1700) | 1600 (1500–1700) |  |
Percentage of | Mean ± SD | 83.11 ± 6.54 | 84.16 ± 5.08 | 76.61 ± 9.99 | < 0.001* |
received energy | Median (IQR) | 85 (80–85) | 85 (80–85) | 75 (70–85) |  |
Received Protein | Mean ± SD | 0.803 ± 0.061 | 0.811 ± 0.051 | 0.751 ± 0.086 | < 0.001* |
(gr) | Median (IQR) | 0.8 (0.8–0.85) | 0.8 (0.8–0.85) | 0.75 (0.7–0.85) |  |
Percentage of | Mean ± SD | 87.57 ± 7.49 | 89.08 ± 5.71 | 78.22 ± 10.04 | < 0.001* |
received Protein | Median (IQR) | 90 (85–90) | 90 (85–90) | 75 (70–85) |  |
MV | Yes (%) | 229 (51.5) | 176 (46) | 53 (85.5) | < 0.001* |
| Â | No (%) | 216 (48.5) | 207 (54) | 9 (14.5) | Â |
MV duration | Mean ± SD | 6.26 ± 3.72 | 2.36 ± 3.07 | 8.55 ± 5.35 | < 0.001* |
(n = 229) | Median (IQR) | 6 (3–8) | 6 (3–8) | 9 (4–12) |  |
ICU LOS | Mean ± SD | 7.38 ± 3.57 (3–21) | 6.81 ± 3.121 | 10.85 ± 4.23 | < 0.001* |
|  | Median (IQR) | 6 (4–10) | 6 (4–10) | 11 (8–14) |  |
Hospital LOS | Mean ± SD | 11.06 ± 4.13 | 10.58 ± 3.84 | 14.03 ± 4.62 | < 0.001* |
|  | Median (IQR) | 10 (7–14) | 10 (7–14) | 14.5 (10–18) |  |
Vasopressor | Yes (%) | 98 (22) | 50 (13.1) | 48 (77.4) | < 0.001* |
| Â | No (%) | 347 (78) | 333 (89.6) | 14 (22.6) | Â |
Days of | Mean ± SD | 3.39 ± 1.78 | 0.33 ± 0.955 | 3.34 ± 2.402 | < 0.001* |
Vasopressor (n = 98) | Median (IQR) | 3 (2–4) | 3 (2–4) | 4 (1–4) |  |
Mortality | Yes (%) | 38 (8.5) | 0 | 38 (61.3) | < 0.001* |
| Â | No (%) | 407 (91.5) | 383 (100) | 24 (38.7) | Â |